Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.00% is 10% above its 5-year average of 52.66%, near the high end of its 5-year range (49.26%–58.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.29% above its 12-month average of 56.70%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
58.00%
GROSS MARGIN AVG TTM
56.70%
GROSS MARGIN AVG 3Y
53.09%
GROSS MARGIN AVG 5Y
52.66%
GROSS MARGIN AVG 10Y
52.19%
GROSS MARGIN AVG 15Y
53.79%
GROSS MARGIN AVG 20Y
54.60%
CURRENT VS TTM AVG
+2.29%
CURRENT VS 3Y AVG
+9.25%
CURRENT VS 5Y AVG
+10.15%
CURRENT VS 10Y AVG
+11.13%
CURRENT VS 15Y AVG
+7.82%
CURRENT VS 20Y AVG
+6.23%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-0.87%
vs the sector median at left
Abbott Laboratories
Market Cap
$179.58B
Gross Margin
58.00%
TTM Avg
56.70%
3Y Avg
53.09%
5Y Avg
52.66%
Market Cap
$160.55B
Gross Margin
79.35%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$211.18B
Gross Margin
40.37%
TTM Avg
39.50%
3Y Avg
40.36%
5Y Avg
43.54%
Market Cap
$134.62B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$126.79B
Gross Margin
68.75%
TTM Avg
62.23%
3Y Avg
59.55%
5Y Avg
57.82%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | $179.58B | 58.00% | 56.70% | 53.09% | 52.66% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 79.35% | 78.55% | 78.10% | 78.28% |
| Amgen Inc. (AMGN)vs › | $202.95B | 71.46% | 66.16% | 69.53% | 71.51% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | 40.37% | 39.50% | 40.36% | 43.54% |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 81.83% | 82.83% | 83.54% | 83.48% |
| Pfizer Inc. (PFE)vs › | $139.86B | 69.35% | 68.05% | 62.23% | 63.06% |
| CVS Health Corp. (CVS)vs › | $137.47B | 13.87% | 13.78% | 14.92% | 15.96% |
| Danaher Corporation (DHR)vs › | $134.62B | 58.51% | 60.22% | 59.98% | 59.48% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 68.75% | 62.23% | 59.55% | 57.82% |
| Stryker Corporation (SYK)vs › | $126.60B | 63.67% | 62.91% | 61.66% | 61.70% |
Gross Margin
58.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 58.00% |
| 2026-03-31 | 56.28% |
| 2025-12-31 | 57.05% |
| 2025-09-30 | 55.75% |
| 2025-06-30 | 56.44% |
| 2025-03-31 | 52.56% |
| 2024-12-31 | 51.01% |
| 2024-09-30 | 51.02% |
| 2024-06-30 | 51.12% |
| 2024-03-31 | 50.40% |
| 2023-12-31 | 51.34% |
| 2023-09-30 | 49.63% |
| 2023-06-30 | 49.56% |
| 2023-03-31 | 49.30% |
| 2022-12-31 | 49.26% |
| 2022-09-30 | 50.04% |
| 2022-06-30 | 51.29% |
| 2022-03-31 | 53.54% |
| 2021-12-31 | 54.14% |
| 2021-09-30 | 55.45% |
| 2021-06-30 | 52.58% |
| 2021-03-31 | 53.27% |
| 2020-12-31 | 53.14% |
| 2020-09-30 | 48.93% |
| 2020-06-30 | 47.50% |
| 2020-03-31 | 50.18% |
| 2019-12-31 | 52.72% |
| 2019-09-30 | 52.13% |
| 2019-06-30 | 52.64% |
| 2019-03-31 | 51.63% |
| 2018-12-31 | 52.58% |
| 2018-09-30 | 52.04% |
| 2018-06-30 | 51.20% |
| 2018-03-31 | 51.14% |
| 2017-12-31 | 49.82% |
| 2017-09-30 | 50.93% |
| 2017-06-30 | 46.08% |
| 2017-03-31 | 43.79% |
| 2016-12-31 | 54.70% |
| 2016-09-30 | 54.17% |
| 2016-06-30 | 57.12% |
| 2016-03-31 | 56.19% |
| 2015-12-31 | 57.48% |
| 2015-09-30 | 56.47% |
| 2015-06-30 | 57.10% |
| 2015-03-31 | 57.50% |
| 2014-12-31 | 56.37% |
| 2014-09-30 | 54.33% |
| 2014-06-30 | 54.85% |
| 2014-03-31 | 52.90% |
| 2013-12-31 | 53.79% |
| 2013-09-30 | 54.37% |
| 2013-06-30 | 53.27% |
| 2013-03-31 | 54.78% |
| 2012-12-31 | 62.54% |
| 2012-09-30 | 62.16% |
| 2012-06-30 | 62.91% |
| 2012-03-31 | 60.61% |
| 2011-12-31 | 63.02% |
| 2011-09-30 | 59.53% |
| 2011-06-30 | 59.75% |
| 2011-03-31 | 57.32% |
| 2010-12-31 | 59.42% |
| 2010-09-30 | 56.86% |
| 2010-06-30 | 59.85% |
| 2010-03-31 | 56.68% |
| 2009-12-31 | 56.95% |
| 2009-09-30 | 56.71% |
| 2009-06-30 | 58.25% |
| 2009-03-31 | 56.30% |
| 2008-12-31 | 60.02% |
| 2008-09-30 | 55.28% |
| 2008-06-30 | 57.35% |
| 2008-03-31 | 56.23% |
| 2007-12-31 | 56.22% |
| 2007-09-30 | 55.09% |
| 2007-06-30 | 55.98% |
| 2007-03-31 | 58.85% |
| 2006-12-31 | 53.91% |
| 2006-09-30 | 57.10% |
| 2006-06-30 | 56.58% |
| 2006-03-31 | 58.14% |
| 2005-12-31 | 53.54% |
| 2005-09-30 | 50.28% |
| 2005-06-30 | 52.35% |
| 2005-03-31 | 53.14% |
| 2004-12-31 | 53.54% |
| 2004-09-30 | 54.83% |
| 2004-06-30 | 56.01% |
| 2004-03-31 | 52.45% |
| 2003-12-31 | 51.94% |
| 2003-09-30 | 51.57% |
| 2003-06-30 | 51.93% |
| 2003-03-31 | 52.02% |
| 2002-12-31 | 50.90% |
| 2002-09-30 | 52.38% |
